Initial Results after Re-Irradiation in Combination with Cetuximab in the Treatment of recurrent Head and Neck Squamous

被引：0
|
作者：
Balermpas, P. [1 ]
Weiss, C. [1 ]
Roedel, C. [1 ]
机构：
[1] Klinikum JW Goethe Univ, Frankfurt, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2011年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [21] LOCATION OF LOCOREGIONAL FAILURE AFTER SALVAGE RE-IRRADIATION OF RECURRENT HEAD AND NECK CANCER
    Sircar, M.
    Koutcher, L.
    Wolden, S.
    Chan, K.
    Zhang, Z.
    Fury, M.
    Sherman, E.
    Wong, R.
    Kraus, D.
    Pfister, D.
    Lee, N.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S322 - S322
  • [22] Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck (vol 191, pg 656, 2015)
    Dornoff, Nicolas
    Weiss, Christian
    Roedel, Franz
    Wagenblast, Jens
    Ghanaati, Shahram
    Nateghian, Atefeh
    Roedel, Claus
    Balermpas, Panagiotis
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (09) : 763 - 763
  • [23] Comment on Dornoff et al.: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck
    Mueller, Klaus
    Klautke, Gunther
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (12) : 985 - 985
  • [24] When is re-irradiation in head and neck squamous cell carcinoma not indicated?
    Primož Strojan
    Jonathan J. Beitler
    Carl E. Silver
    William M. Mendenhall
    Ashok R. Shaha
    Alessandra Rinaldo
    Robert P. Takes
    Alfio Ferlito
    European Archives of Oto-Rhino-Laryngology, 2014, 271 : 3107 - 3109
  • [25] Re-irradiation of head and neck carcinoma
    Mendenhall, William M.
    Mendenhall, Charles M.
    Malillapa, Robert S.
    Palta, Jatinder R.
    Mendenhall, Nancy P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (04): : 393 - 398
  • [26] RE-IRRADIATION IN HEAD AND NECK CANCER
    Lartigau, E.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S16 - S16
  • [27] When is re-irradiation in head and neck squamous cell carcinoma not indicated?
    Strojan, Primoz
    Beitler, Jonathan J.
    Silver, Carl E.
    Mendenhall, William M.
    Shaha, Ashok R.
    Rinaldo, Alessandra
    Takes, Robert P.
    Ferlito, Alfio
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2014, 271 (12) : 3107 - 3109
  • [28] Re-irradiation for oligoprogression under Nivolumab in recurrent head and neck squamous cell carcinoma: A case report
    Bonomo, Pierluigi
    Lucidi, Sara
    Desideri, Isacco
    Scotti, Vieri
    Casati, Marta
    Palomba, Annarita
    Ciabatti, Cinzia
    Garlatti, Pietro
    Massi, Daniela
    Gallo, Oreste
    Livi, Lorenzo
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 23 : 16 - 19
  • [29] Re-irradiation with concurrent Nivolumab in locally recurrent Head and Neck Cancer
    von der Grun, J.
    Altay-Langguth, A.
    Balermpas, P.
    Brandts, C.
    Balster, S.
    Ghanaati, S.
    Winkelmann, R.
    Burck, I.
    Rodel, F.
    Martin, D.
    Rodel, C.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S855 - S855
  • [30] A review on re-irradiation for recurrent and second primary head and neck cancer
    Kasperts, N
    Slotman, B
    Leemans, CR
    Langendijk, JA
    ORAL ONCOLOGY, 2005, 41 (03) : 225 - 243
12345